ESR1 and triple-negative breast carcinoma: Importantly, triple negative breast cancer (TNBC), defined by lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) expression [6], remains associated with shorter disease-free interval and higher mortality rate [7].